Documents released under the Official Information Act

Download documents released about ASH following an Official Information Act request by Calvin Cochran of Vape Free Kids. 

Official Information Act release concerning ASH

On 9 September 2026, the Office of Hon Casey Costello released documents in response to an Official Information Act request submitted by Calvin Cochran on behalf of Vape Free Kids concerning communications involving ASH and the individuals named below.

ASH is publishing the release package as supplied by the Minister’s office so that the correspondence can be read in full and in context. Any redactions in the package were made by the Minister’s office. We routinely do this as we believe in transparency and accountability. 

The request sought:

  1. All correspondence—including email, Teams, Signal, WhatsApp, text messages, phone messages, calls and records of calls—between Minister Costello or members of her office and Robert Beaglehole, Ben Youdan or Ruth Bonita.

  2. Correspondence between the Minister’s office and the Ministry of Health relating to Robert Beaglehole’s attendance at the WHO Framework Convention on Tobacco Control Conference of the Parties, or other events on behalf of the New Zealand Government.

  3. Information covering the period from 27 November 2023.

Please contact ASH if you have any questions about the correspondence or the positions expressed in it.

Download the correspondence released by the Minister’s office (PDF, 66 pages).

The full release is 66 pages, here is a summary of the released papers. (AI generated and checked for clarity)
Overview and Context

This collection of official communications and correspondence (released under New Zealand's Official Information Act 1982) spans August 2024 through June 2026. The material focuses on exchanges between key public health figures—primarily Emeritus Professor Robert Beaglehole and Ben Youdan of Action for Smokefree 2025 (ASH)—and New Zealand government staff, including Private Secretary Brian Watson and Ministerial Advisor Richard Ninness from the office of Hon. Casey Costello (Associate Minister of Health).

Key Themes and Findings

  • New Zealand’s Progress & International Comparisons:

    Correspondence details New Zealand’s decline in daily smoking prevalence (reaching 6.8% in recent health data), outperforming comparable jurisdictions like Australia (8.3%), the UK (12.9%), and the US (11%). Public health leaders attribute the accelerated decline primarily to harm-reduction strategies, particularly regulated vaping products as quit aids. Public health advocates compare NZ's success to international benchmarks, such as Sweden reaching a smoke-free milestone (<5% smoking rate) driven by non-combustible nicotine alternatives.
  • WHO FCTC COP11 & Global Harm Reduction Debates:

    Detailed notes from Prof. Beaglehole’s attendance at the WHO Framework Convention on Tobacco Control (FCTC) COP11 meeting in Geneva (November 2025) highlight a global divide. While NZ promoted its approach as "public health-led, evidence-based, and industry-protected," the WHO and the majority of international parties expressed skepticism toward harm reduction, framing alternative nicotine products mainly as industry tactics. Polarization led to key agenda items regarding alternative nicotine products being deferred to COP12.
  • Regulatory & Policy Initiatives (2024–2026):

    • Vape Starter Kits & "Swap to Stop": ASH strongly endorsed government schemes providing free vape starter kits and targeted support through stop-smoking services, drawing parallels to similar successful schemes in the UK.
    • Alternative Therapies: ASH lobbied Medsafe to reclassify Cytisine (a plant-based smoking cessation medication) as a pharmacist-only medicine to expand cessation options. Additionally, independent research on nicotine pouches was shared as a low-risk alternative to combustible tobacco.
    • Illicit Trade Risks: Communications cite data from Australia showing that strict vape bans and high taxation led to a massive illicit market (50–60% for tobacco and 95.7% for vapes), warning against unintended consequences of prohibitionist policies.
  • Targeted Strategies for Remaining Smokers:

    In early 2026, ASH outlined priorities to address the estimated 294,000 remaining New Zealanders who smoke, particularly focusing on Māori, Pacific populations, and high-deprivation communities. To reach the "Smokefree 2025/26" goal (below 5%), ASH emphasized the need for approximately 80,000 additional quitters through targeted campaigns, expanded quit options, and counteracting public misinformation that conflates vaping with smoking.
  • UK Ministerial Engagement:

    Ahead of Minister Costello’s overseas travel to London in early 2026, ASH leaders arranged connections with leading UK academic and policy experts in tobacco harm reduction and smoking cessation research (such as researchers at King's College London and UCL).
  • Strict Independence from Industry Funding and Influence:

    ASH maintains a strict policy of accepting zero financial support from tobacco, vaping, or pharmaceutical corporations, positioning itself as an independent, public-health-focused advocate while pushing back against global claims that harm reduction strategies are driven by tobacco industry interests.
Conclusion

The documents capture a continuous dialogue aimed at aligning New Zealand policy, academic research, and international advocacy to achieve a smoke-free population by leveraging harm reduction alongside traditional tobacco control measures.

Latest News

See all news >